Microgynon, 150 Mikrogramm / 30 Mikrogramm, überzogene Tabletten, LEVONORGESTREL, ETHINYLESTRADIOL clinical trials

The effect of multiple doses of BI 425809 on the pharmacokinetics of multiple doses of a combination of ethinyl estradiol and levonorgestrel following oral administration in healthy premenopausal female subjects (an open-label, twoperiod, fixed sequence design trial with run-in period)

This study looks at how a new medicine, BI 425809, affects a common type of contraceptive pill (Microgynon) in healthy women. It helps us understand if the new medicine changes how the contraceptive pill works in the body.